(Q37685856)

English

Comparing outcomes of meropenem administration strategies based on pharmacokinetic and pharmacodynamic principles: a qualitative systematic review.

scientific article published on 02 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20124468%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

Comparing outcomes of meropenem administration strategies based on pharmacokinetic and pharmacodynamic principles: a qualitative systematic review (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20124468%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20124468%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Jerrold Perrott

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20124468%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Vincent H Mabasa

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20124468%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

0 references

publication date

2 February 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20124468%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20124468%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

44

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20124468%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20124468%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

557-564

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20124468%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Meropenem pharmacokinetics and penetration into an inflammatory exudate

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Pharmacokinetic and pharmacodynamic properties of meropenem

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Pharmacodynamic target attainment of seven antimicrobials against Gram-negative bacteria collected from China in 2003 and 2004.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Clinical outcomes and cost minimization with an alternative dosing regimen for meropenem in a community hospital

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M339

21 January 2018

Identifiers

10.1345/APH.1M339

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20124468%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20124468%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37685856&oldid=2143840653"